{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:13:11Z","timestamp":1792761191143,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41431-018-0255-7","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:08:23Z","timestamp":1536682103000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent"],"prefix":"10.1038","volume":"27","author":[{"given":"Adeline","family":"Bonnard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Herson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Durr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"255_CR1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.neurol.2015.02.016","volume":"171","author":"S Cl\u00e9ment","year":"2015","unstructured":"Cl\u00e9ment S, Gargiulo M, Feingold J, Durr A. Guidelines for presymptomatic testing for Huntington\u2019s disease: past, present and future in France. Rev Neurol (Paris). 2015;171:572\u201380.","journal-title":"Rev Neurol (Paris)"},{"key":"255_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1399-0004.2012.01900.x","volume":"83","author":"R MacLeod","year":"2013","unstructured":"MacLeod R, Tibben A, Frontali M, Evers-Kiebooms G, Jones A, Martinez-Descales A et al. Recommendations for the predictive genetic test in Huntington\u2019s disease. Clin Genet. 2013;83:221\u201331.","journal-title":"Clin Genet"},{"key":"255_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymgme.2010.12.001","volume":"102","author":"S Dufrasne","year":"2011","unstructured":"Dufrasne S, Roy M, Galvez M, Rosenblatt DS. Experience over fifteen years with a protocol for predictive testing for Huntington disease. Mol Genet Metab. 2011;102:494\u2013504.","journal-title":"Mol Genet Metab"},{"key":"255_CR4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s10897-013-9678-z","volume":"23","author":"TM Scuffham","year":"2014","unstructured":"Scuffham TM, MacMillan JC. Huntington disease: who seeks presymptomatic genetic testing, why and what are the outcomes? J Genet Couns. 2014;23:754\u201361.","journal-title":"J Genet Couns"},{"key":"255_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/(SICI)1096-8628(19991215)88:6<662::AID-AJMG16>3.0.CO;2-A","volume":"88","author":"A Maat-Kievit","year":"1999","unstructured":"Maat-Kievit A, Vegter-Van Der Vlis M, Zoeteweij M, Losekoot M, van Haeringen A, Roos RA. Predictive testing of 25 percent at-risk individuals for Huntington disease (1987-1997). Am J Med Genet. 1999;88:662\u20138.","journal-title":"Am J Med Genet"},{"key":"255_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1034\/j.1399-0004.2000.580107.x","volume":"58","author":"CM Benjamin","year":"2000","unstructured":"Benjamin CM, Lashwood A. United Kingdom experience with presymptomatic testing of individuals at 25% risk for Huntington\u2019s disease. Clin Genet. 2000;58:41\u201349.","journal-title":"Clin Genet"},{"key":"255_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1034\/j.1399-0004.2003.00093.x","volume":"63","author":"S Creighton","year":"2003","unstructured":"Creighton S, Almqvist EW, MacGregor D, Fernandez B, Hogg H, Beis J,\u00a0et al. Predictive, pre-natal and diagnostic genetic testing for Huntington\u2019s disease: the experience in Canada from 1987 to 2000. Clin Genet. 2003;63:462\u201375.","journal-title":"Clin Genet"},{"key":"255_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/ejhg.2016.81","volume":"24","author":"SS Baig","year":"2016","unstructured":"Baig SS, Strong M, Rosser E, Taverner NV, Glew R, Miedzybrodzka Z, et al. 22 Years of predictive testing for Huntington\u2019s disease: the experience of the UK Huntington\u2019s Prediction Consortium. Eur J Hum Genet. 2016;24:1515.","journal-title":"Eur J Hum Genet"},{"key":"255_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1399-0004.2006.00701.x","volume":"70","author":"R Tassicker","year":"2006","unstructured":"Tassicker R, Marshall P, Liebeck T, Keville M, Singaram B, Richards F. Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003). Clin Genet. 2006;70:480\u20139.","journal-title":"Clin Genet"},{"key":"255_CR10","first-page":"673","volume":"8","author":"MK Trembath","year":"2006","unstructured":"Trembath MK, Tassicker RJ, Collins VR, Mansie S, Sheffield LJ, Delatycki MB. Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia. Genet Med J Am Coll Med Genet. 2006;8:673\u201380.","journal-title":"Genet Med J Am Coll Med Genet"},{"key":"255_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/jmg.31.7.555","volume":"31","author":"International Huntington Association and the World Federation of Neurology Research Group on Huntington\u2019s Chorea.","year":"1994","unstructured":"International Huntington Association and the World Federation of Neurology Research Group on Huntington\u2019s Chorea. Guidelines for the molecular genetics predictive test in Huntington\u2019s disease. J Med Genet. 1994;31:555\u20139.","journal-title":"J Med Genet"},{"key":"255_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmg.33.10.856","volume":"33","author":"K Lawson","year":"1996","unstructured":"Lawson K, Wiggins S, Green T, Adam S, Bloch M, Hayden MR. Adverse psychological events occurring in the first year after predictive testing for Huntington\u2019s disease. The Canadian Collaborative Study Predictive Testing. J Med Genet. 1996;33:856\u201362.","journal-title":"J Med Genet"},{"key":"255_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1086\/302374","volume":"64","author":"EW Almqvist","year":"1999","unstructured":"Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet. 1999;64:1293\u2013304.","journal-title":"Am J Hum Genet"},{"key":"255_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1176\/appi.ajp.162.4.725","volume":"162","author":"JS Paulsen","year":"2005","unstructured":"Paulsen JS, Hoth KF, Nehl C, Stierman L. Critical periods of suicide risk in Huntington\u2019s disease. Am J Psychiatry. 2005;162:725\u201331.","journal-title":"Am J Psychiatry"},{"key":"255_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1159\/000327754","volume":"8","author":"JG Fiedorowicz","year":"2011","unstructured":"Fiedorowicz JG, Mills JA, Ruggle A, Langbehn D, Paulsen JS, PREDICT-HD Investigators of the Huntington Study Group. Suicidal behavior in prodromal Huntington disease. Neurodegener Dis. 2011;8:483\u201390.","journal-title":"Neurodegener Dis"},{"key":"255_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/bjp.bp.107.040113","volume":"192","author":"MK Nock","year":"2008","unstructured":"Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192:98\u2013105.","journal-title":"Br J Psychiatry"},{"key":"255_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1034\/j.1399-0004.2001.600606.x","volume":"60","author":"AN Lindblad","year":"2001","unstructured":"Lindblad AN. To test or not to test: an ethical conflict with presymptomatic testing of individuals at 25% risk for Huntington\u2019s disorder. Clin Genet. 2001;60:442\u20136.","journal-title":"Clin Genet"},{"key":"255_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ejhg.2008.146","volume":"17","author":"M Gargiulo","year":"2009","unstructured":"Gargiulo M, Lejeune S, Tanguy ML, Lahlou-Lafor\u00eat K, Faudet A, Cohen D, et al. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet. 2009;17:165\u201371.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0255-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:58:28Z","timestamp":1684616308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0255-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0255-7","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"assertion":[{"value":"5 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}